Tetracycline Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 - 2026

Introduction

Tetracycline drugs are type of antibacterial drugs which are liable for bacterial protein synthesis. This is mainly derived from many straining of Streptomyces bacteria. Tetracyclines are primarily found in two forms such as hydrophilic and lyophilic, which give them admittance to both gram negative as well as gram positive forms of microbial strains. Very a small amount of gram negative bacterial strains own natural resistance over these tetracyclines, which condenses these drugs futile in contradiction of such strains, but no opposition has been witnessed in gram positive strains.

Market Dynamics

Surge in pervasiveness for many bacterial infections across the globe and continuous demand for these drugs amid health care professionals and patients are major factors driving growth of this market. Conversely, accessibility of numerous substitutes for antibacterial drugs and trivial number of unique drugs can sluggish growth of this market. Increasing government initiatives and funding for tetracycline drugs to treat bacterial infections is expected to boost the growth of this market in near future.

Market Classification

The market can be bifurcated on the basis of application, distribution channel, and geography. By application, tetracycline market can be segmented into genital, respiratory, local and systemic and bowel, infections. By distribution channel, tetracycline market can be segmented into hospital pharmacies, retail pharmacies and online pharmacies. On the basis of geography, the tetracycline market can be segmented into North America, Latin America, Europe, Middle East & Africa (MEA) and Asia-Pacific.

Report Coverage

Market Participants

Some of the major players involved in tetracycline market include Pfizer, Inc., Galderma S.A., Lupin Pharmaceuticals, Inc., Novartis AG, Teva Pharmaceutical Industries Limited, Aptalis, Medicis Pharmaceutical Corporation and others

Market Segmentation

Market By Application

Respiratory

Bowel

Genital

Local

Systemic Infections

Market By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Market By Region

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC
• South Africa
• Rest of Middle East & Africa